These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 573605)

  • 21. [Influence of an antispastic, analgesic combination on blood pressure, dynamics and contractility of the left ventricle in the dog].
    Komarek J
    Arzneimittelforschung; 1976; 26(8):1583-8. PubMed ID: 1036957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of maximum left ventricular inotropic response from changes in isovolumic indices of contractility in the dog.
    Broughton A; Korner PI
    Cardiovasc Res; 1981 Jul; 15(7):382-9. PubMed ID: 7307021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the cardiac effects of ASI-222 HCl, an aminosugar cardiac glycoside, and digoxin.
    Cook LS; Caldwell RW; Nash CB
    Arch Int Pharmacodyn Ther; 1977 Jun; 227(2):220-32. PubMed ID: 907408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methionine in protection of hemorrhagic shock: role of oxygen free radicals and hypochlorous acid.
    Prasad K; Kapoor R; Kalra J
    Circ Shock; 1992 Apr; 36(4):265-76. PubMed ID: 1320467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of Vmax in auxotonic systoles from the rate of relative increase of isovolumic pressure: (dP-dt)kP.
    Wolk MJ; Keefe JF; Bing OH; Finkelstein LJ; Levine HJ
    J Clin Invest; 1971 Jun; 50(6):1276-85. PubMed ID: 5578234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The inotropic and beta blocking effects of a chimeric molecule that putatively inhibits both type III phosphodiesterase and beta adrenoceptors in anesthetized dogs.
    Shaffer JE; Grizzle MK; Anderson DK; Wheeler TN
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1105-12. PubMed ID: 8099617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of angiotensin on myocardial contractility.
    Ahmed SS; Levinson GE; Weisse AB; Regan TJ
    J Clin Pharmacol; 1975 Apr; 15(4 Pt 1):276-85. PubMed ID: 236332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QA interval as an indirect measure of cardiac contractility in the conscious telemeterised rat: model optimisation and evaluation.
    Adeyemi O; Roberts S; Harris J; West H; Shome S; Dewhurst M
    J Pharmacol Toxicol Methods; 2009; 60(2):159-66. PubMed ID: 19616109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive inotropic effect of K-canrenoate: an investigation in anaesthetized dogs, untreated or treated with digitalis.
    Marchetti G; Vitolo E; Di Francesco GF; Cavallaro B; Sponzilli C
    Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):250-63. PubMed ID: 6667069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superiority of developed over total pressure for heart contractility indices in dogs.
    Cosyns J; Gutierrez-Miranda M; Reyns P; Charlier AA; Lavenne F
    Pflugers Arch; 1976 Mar; 362(2):165-71. PubMed ID: 944423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of heart rate on left ventricular dp/dt following 1,1,1-trichloroethane inhalation.
    Kobayashi H; Hobara T; Kawamoto T; Tanaka H; Sakai T
    Arch Environ Health; 1988; 43(6):430-5. PubMed ID: 3196079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of heart rate on indices of myocardial contractility in the dog.
    Richmond DR; Angus JA; Goodman AH; Cobbin LB
    Clin Exp Pharmacol Physiol; 1975; 2(6):469-79. PubMed ID: 1236601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the cardiac efficacy of helveticosol-3',4'-di-nitrate, a new glycoside.
    Haustein KO; Nowak G
    Arch Int Pharmacodyn Ther; 1979 Jun; 239(2):270-82. PubMed ID: 485727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The first derivative of the transthoracic electrical impedance as an index of changes in myocardial contractility in the intact anaesthetised dog.
    Welham KC; Mohapatra SN; Hill DW; Stevenson L
    Intensive Care Med; 1978 Jan; 4(1):43-50. PubMed ID: 621315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preload dependence of dP/dt max, VCE max and calculated V max compared to the inotropic sensitivity of these indices of cardiac contractility.
    Schmidt HD; Hoppe H
    Basic Res Cardiol; 1978; 73(4):380-93. PubMed ID: 697709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by Anvirzel and its cardiac glycoside component, oleandrin.
    Smith JA; Madden T; Vijjeswarapu M; Newman RA
    Biochem Pharmacol; 2001 Aug; 62(4):469-72. PubMed ID: 11448457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycoside oleandrin downregulates toll-like receptor pathway genes and associated miRNAs in human melanoma cells.
    Eroğlu Güneş C; Seçer Çelik F; Seçme M; Elmas L; Dodurga Y; Kurar E
    Gene; 2022 Nov; 843():146805. PubMed ID: 35964872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Therapeutic Potential of Cardioactive Glycosides in Doxorubicin Model of Heart Failure.
    da Silva Ferreira R; Fernandes PBU; da Cruz JPO; Silva FLA; Lempek MR; Canta GN; Veado JCC; Mantovani MM; Botelho AFM; Melo MM
    Cardiovasc Toxicol; 2022 Jan; 22(1):78-87. PubMed ID: 34655414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Glycoside Oleandrin Reduces Glioma Growth with Direct and Indirect Effects on Tumor Cells.
    Garofalo S; Grimaldi A; Chece G; Porzia A; Morrone S; Mainiero F; D'Alessandro G; Esposito V; Cortese B; Di Angelantonio S; Trettel F; Limatola C
    J Neurosci; 2017 Apr; 37(14):3926-3939. PubMed ID: 28292827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oleandrin, a cardiac glycoside, induces immunogenic cell death via the PERK/elF2α/ATF4/CHOP pathway in breast cancer.
    Li X; Zheng J; Chen S; Meng FD; Ning J; Sun SL
    Cell Death Dis; 2021 Mar; 12(4):314. PubMed ID: 33762577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.